Jonathan Waldstreicher, MD

Dr. Jonathan Waldstreicher, MD, is a dynamic individual with a passion for innovation and building from the ground up.

His educational background includes a study of MD/MBA in Healthcare Management from Tufts University School of Medicine, a Bachelor of Arts (BA) in Economics from Brandeis University, and studies at Ramaz.

With a rich history in various organizations, Dr. Waldstreicher has held key positions such as Founder & CEO at Galvanize Therapeutics, Inc., Partner at Apple Tree Partners, Founder & CEO at Galaxy Medical, Director on the Board of Directors at ROX Medical and Tusker Medical, Inc., and leadership roles at Gala Therapeutics, Galaxy Medical, and Johnson & Johnson.

His professional experience encompasses roles like Director of Emerging Technologies at Johnson & Johnson, Associate Director of Emerging Technologies and Innovation at Johnson & Johnson's Corporate Office of Science & Technology, Surgery Intern at Tufts Medical Center, Consultant at Johnson & Johnson's Corporate Office of Science & Technology, and Fellow in the Corporate Office of Science and Technology at Johnson & Johnson.

Dr. Waldstreicher's expertise and dedication are evident in his extensive career, showcasing a strong background in entrepreneurship, healthcare management, innovation, and leadership in the medical and corporate sectors.